SBRI: antimicrobial resistance (AMR) in humans
Organisations can apply to develop innovations that address the challenges of antimicrobial resistance (AMR) in humans.
Competition opens: Monday 16 July 2018
Registration closes: Wednesday 22 August 2018 12:00pm
This is a Small Business Research Initiative (SBRI) competition to address antimicrobial resistance (AMR)
The Department of Health and Social Care (DHSC) will invest up to £10 million in 2 simultaneous competition strands.
Strand 1 projects must explore the scientific and technical feasibility of innovative solutions through proof of concept studies. They must focus on infection prevention and the development of new therapies and vaccines in relation to AMR.
Strand 2 projects should be technically more advanced and can include:
- proof of concept in a model system
- progression of a technical evaluation to the point of readiness for clinical testing
- demonstration of effectiveness in humans, patients or the relevant environment